← Back
$SYRE All transactions

Spyre Therapeutics, Inc.

▼ SELL

$ Value

$300K

Shares

18,428

Price

$16

Filed

Sep 3

Insider

Name

Burrows Scott L

Title

Chief Financial Officer

CIK

0001853327

Roles

Officer

Transaction Details

Transaction Date

2025-09-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

97,994

Footnotes

The transaction reported reflects the sale of shares of common stock, par value $0.0001 per share, of the Issuer ("Common Stock") in satisfaction of the Reporting Person's tax liability in connection with the settlement of 33,738 restricted stock units ("RSUs"). This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade made by the Reporting Person. | The price reported is a weighted average sale price of the Common Stock. These shares were sold in multiple transactions at prices ranging from $16.26 to $16.30, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Includes 67,476 RSUs. Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.

Filing Info

Accession No.

0001636282-25-000095

Form Type

4

Issuer CIK

0001636282

Burrows Scott L's History

Date Ticker Type Value
2026-04-01 SYRE M $109K
2026-04-01 SYRE $305K
2026-04-01 SYRE $65K
2026-04-01 SYRE M $0
2025-09-02 SYRE $300K

Other Insiders at SYRE (90d)

Insider Bought Sold Last
Turtle Cameron
Chief Executive Officer
$740K 2026-04-01
Burrows Scott L
Chief Financial Officer
$370K 2026-04-01
Sloan Sheldon
Chief Medical Officer
$398K 2026-04-01